Navigation Links
Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
Date:1/26/2009

kets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent PC system, which we believe is the only FDA-approved minimally invasive nerve stimulation device designed for office-based treatment of urinary urgency, urinary frequency and urge incontinence - symptoms often associated with overactive bladder.

We also offer Macroplastique(R) Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

Forward Looking Information

This press release contains forward-looking statements, which reflect our best estimates regarding future events and financial performance. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results. We discuss in detail the factors that may effect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC. Further, we cannot assure you that the SUmiT clinical trial will produce favorable results, that even if it produces favorable results third-party payers will provide or continue to provide coverage and reimbursement, or reimburse the providers an amount sufficient to cover their costs and expenses, or that even succeed at all at obtaining a specific "listed" CPT code from the AMA for Urgent PC treatments.

For more information about the Urgent(R) PC Neuromodulation System, please call 866-277-0466 or visit www.uroplasty.com.

For Further Information:

    Uroplasty, Inc.                               EVC Group
    David Ka
'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) has ... Global Strategic Business Report" report to their offering. ... Mammography Equipment in US$ Thousands by the following Product ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific ...
(Date:4/17/2015)... , Apr. 16, 2015 Research and Markets ... of the "Corporate Reputation of Pharma in 2014 ... edition" report to their offering. This ... from 130 patient groups with an interest in diabetes ... (and of the pharma industry as a whole) in ...
(Date:4/17/2015)... 17, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a ... innovative therapeutics for the treatment of cancer and diseases ... of data from three of its most advanced oncology ... (AACR) 106 th Annual Meeting being held from ... USA. The presentation on the ...
Breaking Medicine Technology:Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5
... Corporation (NYSE: SHP ) ("ShangPharma" or ... research and development outsourcing company, today announced that ... strategic partnership with Jiangsu Hengrui Medicine Co., Ltd. ... novel therapeutic monoclonal antibodies ("mAbs"). ...
... WOBURN, Mass., Jan. 19, 2012  CutisPharma, Inc. announced ... - Lansoprazole Unit-of-Use oral suspension compounding kits. These ... prescriptions containing widely used proton pump inhibitors (PPIs). ... take up to several hours to prepare and ...
Cached Medicine Technology:ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui 2ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui 3ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui 4CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits 2
(Date:4/18/2015)... (PRWEB) April 18, 2015 "I recognized ... stretchers in healthcare facilities," said an inventor from Cincinnati, ... storage system." , He developed the Slyde Door to ... used in healthcare facilities. It provides convenient storage space ... are more stretchers available for patients. , This ...
(Date:4/18/2015)... has released a new blog post explaining how to ... Clients can review important auto insurance quotes online, by ... advantages for clients who need affordable financial security for ... coverage for their vehicles can purchase a policy at ... agencies offer important discounts and drivers can learn more ...
(Date:4/18/2015)... April 18, 2015 Patients who undergo ... developing mesothelioma later in life, but the disease is ... that is unrelated to radiation. Surviving Mesothelioma has just ... website. Click here to read it now. ... the cases of 45 patients who had both a ...
(Date:4/18/2015)... than 2000 styles of newly designed prom dresses are ... carrying celebrity inspired special occasion dresses. With the prom ... for their prom. For those who are still looking ... be an ideal choice. , "We have by ... the most loved styles seen at this years major ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part ... latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... In a turbulent world, people may find themselves in dangerous ... their first move, but some situations can be avoided if ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2
... days after trauma, developers say , WEDNESDAY, Sept. 12 ... monitor blood flow through the brain in real time, ... head injuries. , Brain trauma is a top killer ... suffer brain injuries annually, according to the U.S. Centers ...
... Scientists have identified a distinct subpopulation of cancer stem ... deadly human pancreatic cancer. The research, published by Cell ... Stem Cell, provides insight into the role of CSCs ... directions for development of more effective therapeutics. , Pancreatic ...
... - Treatment in private doctors, offices with FDA-approved medication could, ... ... killers-, RICHMOND, Va., Sept. 12 ... released by the Substance Abuse and,Mental Health Services Administration (SAMHSA), shows that ...
... EXTON, Pa., Sept. 12 Kensey Nash Corporation,(Nasdaq: ... earnings results,for its first quarter ended September 30, 2007 ... Joe Kaufmann, President and CEO, will be hosting ... 2007 at 9:00 A.M.,Eastern Time. To participate in ...
... against macular degeneration, study finds , WEDNESDAY, Sept. 12 ... the yellow plant pigments lutein and zeaxanthin may have ... a leading cause of irreversible blindness among the elderly. ... supported by the U.S. government, looked at more than ...
... 12, 2007 Rice University chemists have discovered a way ... onto tiny gold spheres. The result is a tiny ball, ... with the drug. , Paclitaxel, which is sold under the ... their inner works. , "Paclitaxel is one of the most ...
Cached Medicine News:Health News:Imaging Software Helps Track, Treat Injured Brains 2Health News:Cancer stem cell subpopulation drives metastasis of human pancreatic cancer 2Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 2Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 3Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 4Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 5Health News:Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference 2Health News:Taxol bristle ball: a wrench in the works for cancer 2
... double spot test is a rapid, ... antibodies to T. cruzi in human ... samples. This test is intended primarily ... reactive samples should be confirmed by ...
... is intended for the immunochromatographic, qualitative ... samples.,Smart Strip Gonorrhea is based on ... the determination of gonorrhea antigen in ... urinary system as an aid in ...
Inquire...
For the rapid determination of human chorionic gonadotropin (hCG) in urine and serum. The test strip is used to obtain a visual qualitative result....
Medicine Products: